Atea Pharmaceuticals | DEFA14A: Others
Atea Pharmaceuticals | DEF 14A: Definitive information statements
Atea Pharmaceuticals | 10-K: Annual report
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%), etc.
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%), etc.
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%), etc.
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.51%)
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jean-Pierre Sommadossi(9.6%),JPM Partners LLC(7.1%)
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.412%),Abigail P. Johnson(6.412%)
Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
Atea Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Corcoran Andrea
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sommadossi Jean-Pierre
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Horga Maria Arantxa
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Foster Wayne
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Vavricka John
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hammond Janet MJ
Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data